• Twitter
  • Jobs
ProCURE oncology
  • HOME
  • ABOUT US
  • RESEARCH GROUP
    • Molleví’s Lab
    • Antolin’s Lab
    • Alemany’s & Piulats’s lab
    • Martínez-Balibrea’s Lab
    • Aytes’s Lab
    • Belver’s Lab
    • Pujana’s Lab
    • Menendez’s Lab
    • Sureda’s & Farre’s Lab
    • Casanovas’s Lab
    • Viñals’s lab
  • INNOVATION
  • NEWS
  • CONTACT
  • Menu Menu

Sphingosine-1-Phosphate Receptor 1 Promotes Ovarian Cancer Tumorsphere Proliferation and Metastasis

10 de April de 2026
Int J Cancer. 2026 Apr 9. doi: 10.1002/ijc.70467. Online ahead…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 2026-04-10 10:00:002026-04-10 10:00:00Sphingosine-1-Phosphate Receptor 1 Promotes Ovarian Cancer Tumorsphere Proliferation and Metastasis

A rise in double-strand breaks sensitizes tumors to oxidative metabolism inhibitors

11 de March de 2026
Biomed Pharmacother. 2026 Mar 10;197:119184. doi: 10.1016/j.biopha.2026.119184.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 2026-03-11 10:00:002026-03-11 10:00:00A rise in double-strand breaks sensitizes tumors to oxidative metabolism inhibitors

Bimanual uterine flexion maneuver during transvaginal sonography: optimizing the endometrial angle of insonation

7 de March de 2026
Ultrasound Obstet Gynecol. 2026 Mar 6. doi: 10.1002/uog.70193.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 2026-03-07 11:00:002026-03-07 11:00:00Bimanual uterine flexion maneuver during transvaginal sonography: optimizing the endometrial angle of insonation

Early diagnosis of fetal ganglionic eminence cysts: imaging, outcome and genetic associations, revealing role of mitochondrial dysfunction

12 de February de 2026
Ultrasound Obstet Gynecol. 2026 Feb 12. doi: 10.1002/uog.70180.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 2026-02-12 11:00:002026-02-12 11:00:00Early diagnosis of fetal ganglionic eminence cysts: imaging, outcome and genetic associations, revealing role of mitochondrial dysfunction

Glucose deprivation drives LIF-dependent lung cancer

30 de January de 2026
Nat Metab. 2026 Jan 30. doi: 10.1038/s42255-025-01437-0. Online…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 2026-01-30 11:00:002026-01-30 11:00:00Glucose deprivation drives LIF-dependent lung cancer

Evolution of angiogenic and inflammatory biomarkers in patients with hereditary hemorrhagic telangiectasia during treatment with bevacizumab: study protocol

7 de October de 2025
Rev Clin Esp (Barc). 2025 Oct 5:502370. doi: 10.1016/j.rceng.2025.502370.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 2025-10-07 10:00:002025-10-07 10:00:00Evolution of angiogenic and inflammatory biomarkers in patients with hereditary hemorrhagic telangiectasia during treatment with bevacizumab: study protocol

Anomalies on anterior and posterior complex views in fetuses with partial agenesis of corpus callosum

11 de July de 2025
Ultrasound Obstet Gynecol. 2025 Jul 11. doi: 10.1002/uog.29292.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 2025-07-11 10:00:002025-07-11 10:00:00Anomalies on anterior and posterior complex views in fetuses with partial agenesis of corpus callosum

Transvaginal ultrasound assessment of corpus callosal length in the fetus: multicenter cross-sectional study

5 de May de 2025
Ultrasound Obstet Gynecol. 2025 May 5. doi: 10.1002/uog.29227.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 2025-05-05 10:00:002025-05-05 10:00:00Transvaginal ultrasound assessment of corpus callosal length in the fetus: multicenter cross-sectional study

Harnessing transcriptional regulation of alternative end-joining to predict cancer treatment

10 de March de 2025
NAR Cancer. 2025 Mar 7;7(1):zcaf007. doi: 10.1093/narcan/zcaf007.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 2025-03-10 10:00:002025-03-10 10:00:00Harnessing transcriptional regulation of alternative end-joining to predict cancer treatment

Posterior complex: clue for suspicion of partial agenesis of corpus callosum at fetal brain screening

30 de October de 2024
Ultrasound Obstet Gynecol. 2024 Oct 30. doi: 10.1002/uog.29136.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 2024-10-30 10:00:002024-10-30 10:00:00Posterior complex: clue for suspicion of partial agenesis of corpus callosum at fetal brain screening

Cancer cell plasticity defines response to immunotherapy in cutaneous squamous cell carcinoma

24 de June de 2024
Nat Commun. 2024 Jun 24;15(1):5352. doi: 10.1038/s41467-024-49718-8.ABSTRACTImmune…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 2024-06-24 10:00:002024-06-24 10:00:00Cancer cell plasticity defines response to immunotherapy in cutaneous squamous cell carcinoma

Ovarian cancer relies on the PDGFRβ-fibronectin axis for tumorsphere formation and metastatic spread

27 de November de 2023
Mol Oncol. 2023 Nov 27. doi: 10.1002/1878-0261.13556. Online…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2023-11-27 11:00:002023-11-27 11:00:00Ovarian cancer relies on the PDGFRβ-fibronectin axis for tumorsphere formation and metastatic spread
Page 1 of 10123›»

Filter by categories

  • Alemany’s & Piulats’s lab (131)
  • Antolin's lab (36)
  • Aytes's Lab (24)
  • Belver's Lab (25)
  • Casanovas's Lab (77)
  • Martínez-Balibrea's Lab (43)
  • Menendez's Lab (121)
  • Molleví's Lab (35)
  • Pujana's Lab (110)
  • Sureda's & Farre's Lab (258)
  • Viñals's lab (111)

Twitter

Tweets by ProcureICO
Program Against Cancer Therapeutic Resistance

CONTACT US

Campus IDIBELL
(L’Hospitalet del Llobregat)
Hospital Duran i Reynals, Gran Via 199,
L’Hospitalet del Llobregat,
Barcelona 08908
Tel. +34 93 260 7952

Campus IGTP-IJC
(Badalona)
Campus Can Ruti – IGTP – Building Muntanya,
Rd. Can Ruti, Camí de les escoles s/n,
Badalona, Barcelona 08916
Tel. +34 93 554 3069

Campus IDIBGI
(Girona)
Parc Hospitalari Martí i Julià de Salt, Dr. Castany s/n,
Salt, Girona 17190
Tel. +34 872 987 087

© Copyright - Edisenius
  • Privacy Policy
  • Cookie Policy
  • Legal Notice
Scroll to top
Manage cookie consent
To offer the best experiences, we use technologies such as cookies to store and/or access device information. Consent to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Failure to consent, or withdrawal of consent, may adversely affect certain features and functions.
Functional Always active
Storage or technical access is strictly necessary for the legitimate purpose of allowing the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. Storage or technical access that is used exclusively for anonymous statistical purposes. Without a requirement, voluntary compliance by your Internet service provider, or additional records from a third party, information stored or retrieved solely for this purpose cannot be used to identify you.
Marketing
Storage or technical access is necessary to create user profiles to send advertising, or to track the user on a website or several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
See preferences
{title} {title} {title}